ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (Vaseretic) Nursing Considerations

What is the generic name?

ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE

What is the Trade Name for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE?

Vaseretic

What are the Indications for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE?

• INDICATIONS AND USAGE VASERETIC is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial treatment (see DOSAGE AND ADMINISTRATION ). In using VASERETIC, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that enalapril does not have a similar risk (see WARNINGS ). In considering use of VASERETIC, it should be noted that black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-blacks (see WARNINGS, Head and Neck Angioedema ).

References: https://open.fda.gov/